These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26418501)

  • 1. Thrombosis of multiple angiolipomas due to acenocumarol treatment.
    Álvarez-López MÁ; Salvatierra J; Sanz A
    J Cutan Pathol; 2015 Nov; 42(11):919-20. PubMed ID: 26418501
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of prolonged acenocoumarol therapy on bone density].
    Kiss J; Tihanyi L; Nagy E; Végh Z; Deli A; Tahy A; Korányi L
    Orv Hetil; 1995 Sep; 136(39):2113-5. PubMed ID: 7566945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Safety of aspirin, clopidogrel, and acenocumarol combination in patients requiring anticoagulation].
    Sánchez-Torrijos J; Gudín-Uriel M; Ridocci-Soriano F
    Rev Esp Cardiol; 2006 Dec; 59(12):1345-6. PubMed ID: 17194433
    [No Abstract]   [Full Text] [Related]  

  • 4. [Secondary drug toxiderma to acenocoumarol].
    Khammassi N; Kessentini N
    Pan Afr Med J; 2015; 22():95. PubMed ID: 26848342
    [No Abstract]   [Full Text] [Related]  

  • 5. The blue toe syndrome during oral anticoagulant therapy with acenocoumarol.
    Fernández MA; Andreu R; Fortea JM; Aznar J
    Thromb Haemost; 2001 Apr; 85(4):743. PubMed ID: 11341514
    [No Abstract]   [Full Text] [Related]  

  • 6. Thumbprinting due to ischemic colitis in a patient on oral anticoagulation.
    Crombé D; Pringot J; Van Isveldt J; Van Campenhoudt M
    JBR-BTR; 2002; 85(4):220. PubMed ID: 12403394
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long-term application of warfarin or acenocumarol in patients with fibrillating arrhythmia: the effects compared].
    Kropacheva ES; Panchenko EP; Ataullakhanova DM
    Klin Med (Mosk); 2005; 83(1):24-7. PubMed ID: 15759486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Knowledge of patients undergoing long-term acenocumarol treatment about the safety of anticoagulant therapy].
    Sawicka-Powierza J; Ołtarzewska AM; Chlabicz S
    Pol Merkur Lekarski; 2007 Jan; 22(127):36-40. PubMed ID: 17477088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A complex interaction between antitubercular treatment and acenocoumarol.
    Das S; Behera SK; Ramakrishnan K; Ganesapandian M; Munuswamy H; Selvarajan S
    Eur J Clin Pharmacol; 2020 Jan; 76(1):133-135. PubMed ID: 31664473
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent advances in tumors of adipose tissue.
    Allen PW
    Curr Top Pathol; 1995; 89():215-39. PubMed ID: 7882711
    [No Abstract]   [Full Text] [Related]  

  • 11. [Major hemorrhages associated with long-term treatment with acenocoumarol in patients with venous thromboembolic disease in a rural area of Extremadura (Spain)].
    Calvo Romero JM
    Med Clin (Barc); 2005 Jun; 125(2):76-7. PubMed ID: 15970189
    [No Abstract]   [Full Text] [Related]  

  • 12. [The efficacy and safety of acenocoumarol and warfarin therapy in patients with lower limb deep vein thrombosis].
    Bernát SI; Rókusz L
    Orv Hetil; 2012 May; 153(20):786-90. PubMed ID: 22580505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological interaction of glucosamine sulphate and acenocoumarol].
    Garrote García M; Iglesias Piñeiro MJ; Martín Alvarez R; Pérez González J
    Aten Primaria; 2004 Feb; 33(3):162-3. PubMed ID: 14987502
    [No Abstract]   [Full Text] [Related]  

  • 14. Activated recombinant factor VII to reverse oral anticoagulants for emergent cesarean delivery.
    Morante L; Guasch EV; Palacio F; Gilsanz F
    Anesth Analg; 2006 Jun; 102(6):1902-3. PubMed ID: 16717350
    [No Abstract]   [Full Text] [Related]  

  • 15. CYP2C9 genotyping in acenocoumarol treatment: is it a cost-effective addition to international normalized ratio monitoring?
    Schalekamp T; Boink GJ; Visser LE; Stricker BH; de Boer A; Klungel OH
    Clin Pharmacol Ther; 2006 Jun; 79(6):511-20. PubMed ID: 16765138
    [No Abstract]   [Full Text] [Related]  

  • 16. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
    Veiga F; Escribá A; Maluenda MP; López Rubio M; Margalet I; Lezana A; Gallego J; Ribera JM
    Thromb Haemost; 2000 Oct; 84(4):559-64. PubMed ID: 11057850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low molecular weight heparin (nadroparine) versus oral anticoagulant (acenocoumarol) in the long-term treatment of deep venous thrombosis: comparison of efficacy, safety and hospitalisation period in 105 patients.
    Mazokopakis EE; Vrentzos GE; Ganotakis ES
    Curr Med Res Opin; 2003; 19(6):565-6. PubMed ID: 14594529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparins, acenocoumarol and bone density.
    Wawrzyńska L; Przedlacki J; Hajduk B; Bielska Falda H; Tomkowski W; Torbicki A
    Haemostasis; 2001; 31(1):69-70. PubMed ID: 11408752
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous necrosis induced by acenocoumarol.
    Valdivielso M; Longo I; Lecona M; Lázaro P
    J Eur Acad Dermatol Venereol; 2004 Mar; 18(2):211-5. PubMed ID: 15009309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rectus sheath hematomas caused by acenocumarol overdose].
    Antal A; Kovács Z; Varga J; Horváth L
    Magy Seb; 2010 Jun; 63(3):118-20. PubMed ID: 20570784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.